Minorga (Minoxidil)

Minoxidil, the active ingredient in Minorga, is a potassium channel opener presented as a topical formulation for external use. It is used to stimulate hair growth in individuals with androgenetic alopecia and other forms of hair loss. Minorga is supplied as a licensed, GDP‑compliant product for use in hospitals, pharmacies and clinics worldwide.

GNH USA supplies Minorga as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Minoxidil acts on the hair follicle cycle to address androgen‑dependent hair loss. - Androgenetic alopecia (male pattern): promotes regrowth of scalp hair and increases hair density. - Androgenetic alopecia (female pattern): helps restore hair thickness and reduces shedding. - General hair loss: supports the anagen phase of hair follicles to improve overall hair coverage.

Common Side Effects: - Scalp irritation: redness, itching, or burning sensation at the application site. - Dryness or flaking of the scalp. - Contact dermatitis: localized rash or swelling. - Unwanted facial hair growth if the product spreads beyond the scalp. - Temporary increase in hair shedding during the first weeks of use.

Serious or Rare Side Effects: - Systemic hypotension or dizziness, especially if applied over large areas. - Tachycardia or palpitations. - Severe allergic reaction: swelling of face, lips, or throat. - Rapid weight gain or edema. - Unexplained chest pain or shortness of breath.

Minorga should be used according to professional guidance and with attention to safety. - Avoid application on irritated, inflamed, or broken skin: may increase absorption and irritation. - Keep product away from eyes, nose and mouth: accidental contact can cause discomfort. - Do not use with other topical vasodilators or overlapping minoxidil products: risk of excess systemic exposure. - Discontinue use and seek medical advice if severe irritation or allergic reaction occurs. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Minorga may interact with certain systemic and topical agents. Major Interactions (Avoid): - Oral antihypertensive drugs (e.g., beta‑blockers, ACE inhibitors): additive blood‑pressure lowering effect. - Systemic vasodilators (e.g., nitroglycerin): may cause excessive hypotension. - Concurrent use of another topical minoxidil product: risk of overdose. Moderate Interactions (Monitor Closely): - Topical corticosteroids: may alter skin absorption. - Alcohol‑based hair products: can increase scalp irritation. - Herbal supplements that affect blood pressure (e.g., ginseng): monitor for dizziness.